Weichunbai Zhang

Dr. Weichunbai Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
SYshuo yin
shuo yin
XZXiaohong Zheng
Xiaohong Zheng
WZWeichunbai Zhang
Weichunbai Zhang
HZHanyun Zhao
Hanyun Zhao
RZRong Zhang
Rong Zhang
FCfeng chen
feng chen
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a type of mature B lymphocyte clonal proliferative tumor with a specific immunophenotype. Bruton tyrosine kinase inhibitors (BTKi) have been approved for the treatment of CLL/SLL. However, the efficacy and safety of new-generation BTKi-based regimens have not been systematically studied. In this systematic review, we evaluated the efficacy and safety of new-generation BTKi-based regimens for the treatment of patients with CLL/SLL. A comprehensive search on PubMed, Embase, Cochrane Library, and ClinicalTrials.gov. up to January 31, 2023, was conducted by us. Studies reporting data on CLL/SLL patients treated with new-generation BTKi were included. We assessed the overall response rate (ORR), complete response (CR) rate, and 24-month OS/PFS rates for efficacy analysis. For safety analysis, we evaluated the incidence of grade ≥ 3 adverse events (AEs). The meta-analysis included twenty studies. The pooled ORR for new-generation BTKi was 92% (95% CI, 89–95%, I2 = 80.68%, P = 0.00), while the pooled CR rate was 10% (95% CI, 6–14%, I2 = 88.11%, P = 0.00). Research has found that the new-generation BTKi-based therapy had higher efficacy under the following treatment conditions: < 65 years old, treatment-naive (TN)-CLL, and BTKi combination therapy. The ORR/CR rates and 24-month OS/PFS rates of BTKi combination therapy were higher than that of BTKi monotherapy. Compared to acalabrutinib monotherapy, zanubrutinib monotherapy demonstrated higher ORR/CR rates and 24-month OS/PFS rates. Common grade ≥ 3 AEs included cytopenia and hypertension. The new-generation BTKi-based therapy has good tolerance and provides incremental benefits for CLL/SLL patients. Despite the superior efficacy of BTKi combination therapy compared to monotherapy, its AEs rates are relatively high. Compared to acalabrutinib, Zanubrutinib may be the preferred monotherapy for CLL. However, randomized-controlled studies are still needed.

17 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
WZWeichunbai Zhang
Weichunbai Zhang
YHYongqi He
Yongqi He
FCfeng chen
feng chen
ZCZe Cai
Ze Cai
XKXun Kang
Xun Kang
WLWenbin Li
Wenbin Li
Identifying modifiable factors in primary prevention strategies is a typical goal of glioma epidemiology. Among many glioma risk factors, diet was always considered as one. Most of the relevant studies thus far were concentrated on the West. It was crucial to investigate the connection between the Chinese diet and gliomas given the stark variations between western and eastern diets. A food frequency questionnaire including 114 items was used to investigate the food intake of the study subjects. The Chinese Dietary Quality Index (CDQI), the Chinese Dietary Balance Index (CDBI), the Dietary Antioxidant Index (DAI), the Dietary Inflammation Index (DII), and the Chinese Healthy Eating Index (CHEI) were calculated based on the data provided by the food frequency questionnaire to evaluate dietary quality, dietary balance, dietary antioxidants, dietary inflammation and adherence to the Chinese dietary guidelines in 506 glioma patients and 506 controls, respectively. After adjusting covariates, CHEI (OR = 0.90, 95% CI: 0.88–0.93) and DAI (OR = 0.61, 95% CI: 0.54–0.70) were correlated to a reduced glioma risk, and CDBI-based undernutrition (OR = 1.08, 95% CI: 1.06–1.12) and overnutrition (OR = 1.14, 95% CI: 1.09–1.20) and DII (OR = 2.20, 95% CI: 1.81–2.68) were correlated to an elevated glioma risk. Moreover, restrictive cubic spline analysis showed that there were significant nonlinear dose–response relationships between CHEI, CDBI, DAI, DII, and glioma. Therefore, adhering to the Chinese dietary guidelines was connected with a lower glioma risk, and undernutrition and overnutrition in the Chinese diet were associated with an increased risk of glioma.

2 June 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
WZWeichunbai Zhang
Weichunbai Zhang
ZCZe Cai
Ze Cai
FCfeng chen
feng chen
YHYongqi He
Yongqi He
SYShuo Yin
Shuo Yin
WLWenbin Li
Wenbin Li
The information about phytochemicals’ potential to prevent cancer is encouraging, including for glioma. However, most studies on phytochemicals and glioma mainly focused on preclinical studies. Their epidemiological studies were not sufficient, and the evidence on the dose–response relationship is usually limited. Therefore, this investigation examined the association between dietary phytochemical intake and glioma in Chinese adults. This case–control study was carried out in a hospital in China. Based on the dietary information obtained from the food frequency questionnaire, the researchers estimated the phytochemical intake of 506 patients with glioma and 506 controls. Compared with participants in the lowest tertile, the highest intakes of carotene, flavonoids, soy isoflavones, anthocyanin, and resveratrol were associated with a reduced risk of glioma. The WQS and BKMR models suggested that anthocyanin and carotene have a greater influence on glioma. The significant nonlinear dose–response associations between dietary phytochemicals and glioma were suggested using the restricted cubic spline function. According to this study on phytochemicals and glioma, higher intakes of carotene, flavonoids, soy isoflavones, anthocyanins, and resveratrol are linked to a lower risk of glioma. So, we might not be able to ignore how phytochemicals affect gliomas.

1 March 2026 in Foods
Verified
Journal Article
Open access
PDF file
SMSheng Ma
Sheng Ma
XMXiaochen Ma
Xiaochen Ma
LHLing Hao
Ling Hao
LYLing Yong
Ling Yong
TOTong Ou
Tong Ou
YSYan Song
Yan Song
L-Ergothioneine (L-EGT), a naturally occurring thiol compound abundant mainly in edible fungi, is increasingly regarded as a potentially beneficial bioactive constituent. However, population-level exposure data remain limited. This study aimed to estimate background dietary exposure to L-EGT among Chinese residents, describe its distribution across population subgroups and regions, identify major food contributors, and characterize the risk using a margin of exposure (MOE) approach. Individual body-weight-normalized L-EGT intakes were estimated from published food concentration data and three-day dietary recalls of 42,218 participants. MOEs were calculated using a no observed adverse effect level (NOAEL) of 800 mg/kg bw/d obtained from subchronic toxicity studies. The mean dietary exposure to L-EGT was 0.043 mg/kg bw/d (MOE = 18,605) in the general population and 0.174 mg/kg bw/d (MOE = 4598) among consumers, with 95th percentile exposures of 0.244 mg/kg bw/d (MOE = 3279) and 0.644 mg/kg bw/d (MOE = 1242), respectively. MOE values were consistently above the safety threshold of 300 across all subgroups, with less than 0.3% of the total population and 1.3% of consumers aged 3–6 years falling below this value. These results indicate that current natural dietary exposure to L-EGT in China is low and does not raise safety concerns and provide essential baseline data for future studies on its health effects, optimal intake ranges, and long-term safety.

23 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
WZWeichunbai Zhang
Weichunbai Zhang
YHYongqi He
Yongqi He
ZCZe Cai
Ze Cai
FCfeng chen
feng chen
BJBo Jiang
Bo Jiang
WLWenbin Li
Wenbin Li
Recent studies have revealed a putative relationship between diet and glioma development and prognosis, but few studies have examined the association between overall diet and glioma risk. This study, conducted in China, employed a hospital-based case-control approach. The researchers utilized an a priori method based on dietary data to evaluate compliance scores for five healthy dietary patterns (the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH) diet, the Mediterranean-DASH diet Intervention for Neurodegenerative Delay (MIND) diet, the Paleolithic diet, and the Planetary Health Diet) in 1012 participants. At the same time, data-driven methods were used to explore the association between dietary patterns and glioma via principal component analysis (PCA). In the multivariate model, adhering to the Mediterranean diet (odds ratio (OR) = 0.29; 95% confidence interval (95% CI): 0.17–0.52), the DASH diet (OR = 0.09; 95% CI: 0.04–0.18), the MIND diet (OR = 0.25; 95% CI: 0.14–0.44), and the Paleolithic diet (OR = 0.13; 95% CI: 0.06–0.25) was associated with a reduced glioma risk. The results of PCA suggested that increasing the intake of plant-based foods and fish and limiting foods rich in carbohydrates, fats, and salts were associated with a reduced glioma risk. There was a substantial nonlinear dose–response association between glioma and the Mediterranean diet score. However, the DASH diet score, the MIND diet score, and the Paleolithic diet score exhibited linear dose–response relationships. Therefore, this study finds that dietary patterns may be an influencing factor for glioma risk.

30 September 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
WZWeichunbai Zhang
Weichunbai Zhang
YPYue Peng
Yue Peng
XKXun Kang
Xun Kang
ZCZe Cai
Ze Cai
FCfeng chen
feng chen
WLWenbin Li
Wenbin Li
Plant-based diets have been suggested to help prevent various chronic diseases, including cancer. However, there are few reports on central nervous system tumors, and data on dose–response relationships are lacking. This individual-matched case–control study included 506 cases and 506 controls. The overall plant-based diet index (PDI), the healthy plant-based diet index (hPDI), and the unhealthy plant-based diet index (uPDI) were calculated using dietary information collected through a food frequency questionnaire, with higher scores indicating better adherence. We analyzed the relationship of plant-based diets with glioma. After adequate adjustment for confounders, PDI was associated with a reduced glioma risk (OR = 0.42, 95% CI: 0.24–0.72). Conversely, uPDI was associated with an elevated glioma risk (OR = 8.04, 95% CI: 4.15–15.60). However, hPDI was not significantly associated with glioma risk (OR = 0.83, 95% CI: 0.48–1.45). For subgroups, PDI was not significant in analyzing young age, BMI, or any pathological subtypes. The restricted cubic spline function showed a significant dose–response relationship between PDI (p-nonlinearity< 0.0001) and uPDI (p-nonlinearity= 0.0711) and glioma. Further analysis found that refined grains had the greatest effect on gliomas in the less healthy plant-based food group. Therefore, following a plant-based diet was linked to a lower risk of glioma, especially when consuming fewer unhealthy plant-based foods.